Quantum Biopharma (QNTM) Stock Price, News & Analysis

Company Overview

Quantum BioPharma is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for neurodegenerative diseases, including Lucid-MS, a first-in-class small molecule drug candidate designed to promote remyelination in patients with Multiple Sclerosis (MS).

Written by Jeffrey Neal Johnson

Key Stats

• Today's Range: $31.91 to $38.25
• 50-Day Range: $6.24 to $30.18
• 52-Week Range: $2.70 to $38.25
• Volume: 825,124 shs
• Average Volume: 946,903 shs
• Market Capitalization: $101.85 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

QNTM Stock Analysis - Frequently Asked Questions

How have QNTM shares performed this year?

Quantum Biopharma's stock was trading at $3.68 on January 1st, 2025. Since then, QNTM shares have increased by 851.1% and is now trading at $35.00.
View the best growth stocks for 2025 here.

How were Quantum Biopharma's earnings last quarter?

Quantum Biopharma Ltd. (NASDAQ:QNTM) announced its quarterly earnings results on Wednesday, May, 14th. The company reported ($1.41) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.37) by $1.04. The company earned $2.09 million during the quarter, compared to the consensus estimate of $2.09 million.

How do I buy shares of Quantum Biopharma?

Shares of QNTM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Quantum Biopharma own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Quantum Biopharma investors own include Jiuzi (JZXN), Aethlon Medical (AEMD), Aditxt (ADTX), Adial Pharmaceuticals (ADIL), Avalon GloboCare (ALBT), Ainos (AIMD) and AMC Entertainment (AMC).

Company Calendar

• Last Earnings: 5/14/2025
• Today: 6/21/2025
• Next Earnings (Estimated): 8/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:QNTM
• Previous Symbol: NASDAQ:QNTM
• CIK: 1771885
• Web: www.fsdpharma.com
• Phone: 416-854-8884
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($15.98)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$14.20 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -155.20%
• Return on Assets: -94.90%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.96
• Quick Ratio: 0.95

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $4.54 per share
• Price / Book: 7.71

Miscellaneous

• Outstanding Shares: 2,910,000
• Free Float: 2,660,000
• Market Cap: $101.85 million
• Optionable: N/A
• Beta: 0.55